Loading clinical trials...

A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT02910635

A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers

The primary objective of this study is to assess the corrected QT interval (QTc) effect of volanesorsen (ISIS 304801) administered as a 300 mg subcutaneous (SC) therapeutic and a 300 mg intravenous (I...

Lead sponsor: Ionis Pharmaceuticals, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

TERMINATED

Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging

NCT00593541 · Abnormalities, Cardiovascular

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 28, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment52

Start dateSep 2016

Last updatedJan 28, 2022

Condition

Abnormalities, Cardiovascular

Locations shown

Covance

Dallas, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 28, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions